Literature DB >> 12022998

Decreased gallbladder response in leptin-deficient obese mice.

Matthew I Goldblatt1, Deborah A Swartz-Basile, Carol L Svatek, Atilla Nakeeb, Henry A Pitt.   

Abstract

Obesity is a major risk factor for gallstone formation, but the pathogenesis of this phenomenon remains unclear. Human data on gallbladder emptying are conflicting, and no animal data exist on the effect of obesity on gallbladder motility. Leptin, a hormone produced by adipocytes, is known to have central effects on neuropeptide Y and cholecystokinin, but the influence of leptin on the biliary effects of these hormones is unknown. Therefore we tested the hypothesis that leptin-deficient C57BL/6J-lep(ob) obese mice would have decreased gallbladder responses to excitatory stimuli. Twelve-week-old lean control (C57BL/6J) (n = 22) and C57BL/6J-lep(ob) obese (n = 20) female mice were fed a nonlithogenic diet. The mice were fasted overnight and underwent cholecystectomy. Whole gallbladders were placed in 3 ml muscle baths. After optimal length was determined with acetylcholine (10(-5) mol/L, responses to increasing doses of neuropeptide Y (10(-8) to 10(-6) mol/L) and cholecystokinin-8 (10(-10) to 10(-7) mol/L) were measured. Student's t test and two-way analysis of variance were used where appropriate. Results were expressed as Newtons per cross-sectional area. The lean control mice had significantly greater excitatory responses to acetylcholine than the obese mice (0.37 +/- 0.05 vs. 0.16 +/- 0.02, P < 0.01). The gallbladder responses were also greater when mice were treated with neuropeptide Y (10(-8) mol/L: 0.00 +/- 0.00 vs. 0.00 +/- 0.00, NS; 10(-7) mol/L: 0.12 +/- 0.02 vs. 0.05 +/- 0.01, P < 0.01; 10(-6) mol/L: 0.26 +/- 0.08 vs. 0.06 +/- 0.01, P < 0.01) and cholecystokinin (10(-10) mol/L: 0.27 +/- 0.04 vs. 0.13 +/- 0.02, P < 0.01; 10(-9) mol/L: 0.59 +/- 0.08 vs. 0.27 +/- 0.04, P < 0.01; 10(-8) mol/L: 0.80 +/- 0.11 vs. 0.37 +/- 0.05, P < 0.01; 10(-7) mol/L: 0.86 +/- 0.11 vs. 0.44 +/- 0.06, P < 0.01). These data suggest that genetically obese, leptin-deficient mice have decreased responses to acetylcholine, neuropeptide Y, and cholecystokinin. We conclude that decreased gallbladder motility contributes to the increased incidence of gallstones associated with obesity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022998     DOI: 10.1016/s1091-255x(01)00046-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

1.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.

Authors:  M D Barrachina; V Martínez; L Wang; J Y Wei; Y Taché
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

2.  Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal, and muscular normal) people.

Authors:  W C Vezina; R L Paradis; D M Grace; R A Zimmer; D D Lamont; K M Rycroft; M E King; L C Hutton; W Y Chey
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

3.  Cholinergic effects on gallbladder emptying in humans.

Authors:  R S Fisher; E Rock; L S Malmud
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

4.  Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse.

Authors:  J P Wilding; S G Gilbey; C J Bailey; R A Batt; G Williams; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  1993-05       Impact factor: 4.736

5.  Gallbladder disease in the morbidly obese.

Authors:  J F Amaral; W R Thompson
Journal:  Am J Surg       Date:  1985-04       Impact factor: 2.565

6.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

7.  Ultrasonographic study of gall-bladder emptying in obese patients.

Authors:  M Acalovschi; R Badea
Journal:  Int J Obes Relat Metab Disord       Date:  1992-04

8.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

9.  Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.

Authors:  E A Shaffer; D M Small
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  The integrity of the cholecystokinin receptor gene in gallbladder disease and obesity.

Authors:  G Nardone; I A Ferber; L J Miller
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  17 in total

Review 1.  Effects of bioactive agents on biliary motor function.

Authors:  Charmaine M Woods; Gary M Mawe; Eldon A Shaffer; James Toouli; Gino T P Saccone
Journal:  Curr Gastroenterol Rep       Date:  2003-04

2.  Resistin-like molecule alpha reduces gallbladder optimal tension.

Authors:  Hayder H Al-Azzawi; Abhishek Mathur; Debao Lu; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

3.  Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects.

Authors:  Nahum Méndez-Sánchez; Luisa-B Bermejo-Martínez; Yolanda Viñals; Norberto-C Chavez-Tapia; Irina Vander Graff; Guadalupe Ponciano-Rodríguez; Martha-H Ramos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

4.  Nonalcoholic Fatty gallbladder disease: the influence of diet in lean and obese mice.

Authors:  Matthew I Goldblatt; Deborah A Swartz-Basile; Hayder H Al-Azzawi; Khoi Q Tran; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

5.  Steatocholecystitis: the influence of obesity and dietary carbohydrates.

Authors:  Abhishek Mathur; Hayder H Al-Azzawi; Debao Lu; Kyle W Yancey; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  J Surg Res       Date:  2007-10-22       Impact factor: 2.192

6.  Cholecystosteatosis: an explanation for increased cholecystectomy rates.

Authors:  Hayder H Al-Azzawi; Attila Nakeeb; Romil Saxena; Mary A Maluccio; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

Review 7.  Steatocholecystitis and fatty gallbladder disease.

Authors:  Chung-Jyi Tsai
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

8.  Biliary lipids and cholesterol crystal formation in leptin-deficient obese mice.

Authors:  Deborah A Swartz-Basile; Matthew I Goldblatt; Seong Ho Choi; Carol Svatek; Khoi Tran; Attila Nakeeb; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

9.  Diminished gallbladder motility in Rotund leptin-resistant obese mice.

Authors:  Shannon J Graewin; Khoi Q Tran; Jurgen K Naggert; Keun-Ho Lee; Debbie Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

10.  GRP78 rescues the ABCG5 ABCG8 sterol transporter in db/db mice.

Authors:  Yuhuan Wang; Kai Su; Nadezhda S Sabeva; Ailing Ji; Deneys R van der Westhuyzen; Fabienne Foufelle; Xia Gao; Gregory A Graf
Journal:  Metabolism       Date:  2015-08-15       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.